Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

65 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Glioblastoma stem cells express non-canonical proteins and exclusive mesenchymal-like or non-mesenchymal-like protein signatures.
Babačić H, Galardi S, Umer HM, Hellström M, Uhrbom L, Maturi N, Cardinali D, Pellegatta S, Michienzi A, Trevisi G, Mangiola A, Lehtiö J, Ciafrè SA, Pernemalm M. Babačić H, et al. Among authors: pellegatta s. Mol Oncol. 2023 Feb;17(2):238-260. doi: 10.1002/1878-0261.13355. Epub 2023 Jan 16. Mol Oncol. 2023. PMID: 36495079 Free PMC article.
Resetting cancer stem cell regulatory nodes upon MYC inhibition.
Galardi S, Savino M, Scagnoli F, Pellegatta S, Pisati F, Zambelli F, Illi B, Annibali D, Beji S, Orecchini E, Alberelli MA, Apicella C, Fontanella RA, Michienzi A, Finocchiaro G, Farace MG, Pavesi G, Ciafrè SA, Nasi S. Galardi S, et al. Among authors: pellegatta s. EMBO Rep. 2016 Dec;17(12):1872-1889. doi: 10.15252/embr.201541489. Epub 2016 Nov 16. EMBO Rep. 2016. PMID: 27852622 Free PMC article.
Dendritic cell vaccines for cancer stem cells.
Pellegatta S, Finocchiaro G. Pellegatta S, et al. Methods Mol Biol. 2009;568:233-47. doi: 10.1007/978-1-59745-280-9_15. Methods Mol Biol. 2009. PMID: 19582431
Perspectives for immunotherapy in glioblastoma treatment.
Finocchiaro G, Pellegatta S. Finocchiaro G, et al. Among authors: pellegatta s. Curr Opin Oncol. 2014 Nov;26(6):608-14. doi: 10.1097/CCO.0000000000000135. Curr Opin Oncol. 2014. PMID: 25210870 Review.
MET inhibition overcomes radiation resistance of glioblastoma stem-like cells.
De Bacco F, D'Ambrosio A, Casanova E, Orzan F, Neggia R, Albano R, Verginelli F, Cominelli M, Poliani PL, Luraghi P, Reato G, Pellegatta S, Finocchiaro G, Perera T, Garibaldi E, Gabriele P, Comoglio PM, Boccaccio C. De Bacco F, et al. Among authors: pellegatta s. EMBO Mol Med. 2016 May 2;8(5):550-68. doi: 10.15252/emmm.201505890. Print 2016 May. EMBO Mol Med. 2016. PMID: 27138567 Free PMC article.
Genetic Evolution of Glioblastoma Stem-Like Cells From Primary to Recurrent Tumor.
Orzan F, De Bacco F, Crisafulli G, Pellegatta S, Mussolin B, Siravegna G, D'Ambrosio A, Comoglio PM, Finocchiaro G, Boccaccio C. Orzan F, et al. Among authors: pellegatta s. Stem Cells. 2017 Nov;35(11):2218-2228. doi: 10.1002/stem.2703. Epub 2017 Sep 29. Stem Cells. 2017. PMID: 28895245 Free article.
NG2/CSPG4 in glioblastoma: about flexibility.
Finocchiaro G, Pellegatta S. Finocchiaro G, et al. Among authors: pellegatta s. Neuro Oncol. 2019 Jun 10;21(6):697-698. doi: 10.1093/neuonc/noz055. Neuro Oncol. 2019. PMID: 30918960 Free PMC article. No abstract available.
65 results